Non‐invasive characterization of melanoma depth at single‐cell resolution
Open Access
- 3 July 2025
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (11) , 1945-1954
Abstract
Background: Efficient staging and management of cutaneous melanoma, one of today's deadliest skin cancers, requires non‐invasive determination of tumour depth (Breslow depth). However, current imaging technologies lack the necessary contrast or penetration to measure Breslow depth. Objectives: To determine if raster‐scanning optoacoustic mesoscopy (RSOM) can fill this gap in dermatology. Methods: We used phantoms to optimize RSOM for melanoma imaging and demonstrated its capability to image melanocytes at single‐cell resolution in deep tissue. We then compared RSOM's ability to measure Breslow depth against the clinical standard in a pilot study. For the phantoms studies, we compared the ability of an optimized RSOM system to measure the concentration and diameter of single melanoma cells against gold‐standard microscopy methods. For the pilot clinical study, we used linear regression to compare RSOM's Breslow depth against the clinical standard, obtaining the goodness of fit ( R 2 ) and the p ‐value. For the pilot clinical study, we imaged nine lesions: 7 superficially spreading melanomas, 1 benign dysplastic nevus and 1 blue nevus. The average age of the patients was 56.2 ± 12.5 years. We also imaged 10 non‐lesional skin areas from healthy volunteers. Results: By utilizing ultra‐wideband frequency detection and optimized illumination wavelength, we show that RSOM achieves non‐invasive imaging of melanoma at the resolution of single melanocytes, penetrating more than 3 mm into the skin. The agreement between RSOM and the standard‐of‐care histological assessment was R 2 = 0.886 ( p = 0.0002) for Breslow depth determination. Conclusions: RSOM provides non‐invasive imaging performance that correlates with the Breslow depth determination. Further work is needed to confirm these findings and to test RSOM against other non‐invasive methods.Keywords
Funding Information
- HORIZON EUROPE European Innovation Council (101046667)
- Comunidad de Madrid (2020‐T1/TIC‐20661TEC)
- Bundesministerium für Forschung, Technologie und Raumfahrt (03VP102070)
- Horizon 2020 Framework Programme (862811, 871763)
This publication has 31 references indexed in Scilit:
- Fast raster-scan optoacoustic mesoscopy enables assessment of human melanoma microvasculature in vivoNature Communications, 2022
- Optoacoustic mesoscopy for biomedicineNature Biomedical Engineering, 2019
- Assessing nailfold microvascular structure with ultra-wideband raster-scan optoacoustic mesoscopyPhotoacoustics, 2018
- Noninvasive Determination of Melanoma Depth using a Handheld Photoacoustic ProbeJournal of Investigative Dermatology, 2017
- Precision assessment of label-free psoriasis biomarkers with ultra-broadband optoacoustic mesoscopyNature Biomedical Engineering, 2017
- In Vivo Reflectance Confocal Microscopy Enhances Secondary Evaluation of Melanocytic LesionsJournal of Investigative Dermatology, 2009
- Characterization of benign and malignant melanocytic skin lesions using optical coherence tomography in vivoJournal of the American Academy of Dermatology, 2007
- Preoperative Melanoma Thickness Determination by 20-MHz Sonography and Digital Videomicroscopy in CombinationArchives of Dermatology, 2003
- Sentinel Lymph Node Evaluation in MelanomaArchives of Dermatology, 1997
- Management of Early-Stage Melanoma by Intraoperative Lymphatic Mapping and Selective Lymphadenectomy: An Alternative to Routine Elective Lymphadenectomy or “Watch and Wait”Surgical Oncology Clinics of North America, 1992